Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dydrogesterone Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in Hormone Replacement Therapy (HRT) Frozen Embryo Transfer (FET) Cycles.

NCT04758871 is registered in ClinicalTrials.gov with CRG UZ Brussel as lead sponsor.

NCT NCT04758871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04758871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dydrogesterone Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in Hormone Replacement Therapy (HRT) Frozen Embryo Transfer (FET) Cycles.
Lead sponsor
CRG UZ Brussel
Phase
Phase 4
Overall status
Completed
Start date
October 1, 2021
Completion date
June 13, 2024
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dydrogesterone, frozen embryo transfer, hormone replacement therapy, infertility, female